title: Intravascular large B cell lymphoma with haemophagocytic syndrome: a double lethal masquerade.
authors.affiliation: Department of General Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
authors.forename: N R
authors.initials: NR
authors.lastname: Adler
authors.affiliation: Department of General Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
authors.forename: C S B
authors.initials: CS
authors.lastname: Sia
authors.affiliation: Department of General Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
authors.forename: C
authors.initials: C
authors.lastname: Polchleb
authors.affiliation: Department of Haematology, Alfred Hospital, Melbourne, Victoria, Australia.|Monash University, Melbourne, Victoria, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Jane
authors.affiliation: Department of General Medicine, Alfred Hospital, Melbourne, Victoria, Australia.|Deparment of Infectious Diseases, Alfred Hospital, Melbourne, Victoria, Australia.|Monash University, Melbourne, Victoria, Australia.
authors.forename: A K
authors.initials: AK
authors.lastname: Aung
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis; D003072:Cognition Disorders / Q000209:etiology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D005335:Fever of Unknown Origin / Q000209:etiology; D006801:Humans; D051359:Lymphohistiocytosis, Hemophagocytic / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D000069283:Rituximab / Q000008:administration & dosage; D016896:Treatment Outcome; D019043:Vascular Neoplasms / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D015431:Weight Loss
chemical_list: D014408:Biomarkers, Tumor; D000069283:Rituximab; D003907:Dexamethasone; D003520:Cyclophosphamide